Home > Healthcare > Pharmaceuticals > Finished Drug Form > blood platelet market
Get a free sample of Blood Platelets Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Blood Platelets Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Blood Platelets Market size was valued at USD 5.6 billion in 2023 and is expected to exhibit growth at a CAGR of 4.2% from 2024 to 2032. The increasing prevalence of chronic and blood-related disorders coupled with growing demand for blood transfusions are significantly driving the market growth.
The growing incidence of chronic and blood-related disorders is a key factor driving the expansion of the market. Conditions such as cancer, cardiovascular diseases, and hemophilia frequently result in platelet deficiencies, fueling the need for platelet transfusions. Factors behind this trend include an aging population, lifestyle-related health issues, and increasing cancer rates. For instance, according to the World Health Organization, cardiovascular diseases are responsible for 17.9 million deaths annually, many involving platelet therapies. As the prevalence of these chronic and blood-related disorders continues to rise, the demand for blood platelets is expected to grow, further driving the market's expansion in the coming years.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Blood Platelets Market Size in 2023: | USD 5.6 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2023 - 2032 CAGR: | 4.2 |
2023 Value Projection: | USD 8.3 Billion |
Historical Data for: | 2021-2023 |
No of Pages: | 100 |
Tables, Charts & Figures: | 161 |
Segments Covered: | Platelet Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Moreover, the growing demand for blood transfusions diagnostics, particularly in trauma cases and surgical procedures, is further propelling the need for blood platelets. This increasing reliance on platelet transfusions is expected to significantly contribute to the sustained growth of the blood platelets market.
Blood platelets are small, disc-shaped cell fragments in the blood that play a crucial role in hemostasis, the process of stopping bleeding. They are produced in the bone marrow from larger cells called megakaryocytes and lack a nucleus, making them unique among blood components.
The rise in awareness regarding blood donations and platelet transfusions is emerging as a significant trend in the market.
Based on platelet type, the market is classified into apheresis derived platelets and whole-blood derived platelet. The apheresis derived platelets segment generated the highest revenue of USD 3 billion in 2023.
Based on application, the blood platelets market is categorized into thrombocytopenia, hemato-oncology, perioperative indications, hemophilia, platelet function disorders, and other applications. The thrombocytopenia segment dominated the market by obtaining 44.3% of market share in 2023.
Based on end-use, the blood platelets market is segmented into hospitals, ambulatory surgical centers, and other end-users. The hospitals segment dominated the market in 2023 and is anticipated to reach USD 6.7 billion by 2032.
North America blood platelets market accounted for USD 1.5 billion market revenue in 2023 and is anticipated to grow at CAGR of 2.8% between 2024 and 2032.
U.S. blood platelets market accounted for USD 1.5 billion market revenue in 2023 and is estimated to hold substantial share between 2024 – 2032 period.
UK blood platelets market is projected to grow remarkably in the coming years.
Japan holds a dominant position in the Asia Pacific blood platelets market.
The market is dominated by some of the major market players. The market is fragmented in nature, with major organizations, local small players, and start-ups joining the industry competition. The key industry players are consistently involved in creating new opportunities in the healthcare sector. Few of the players operating in the market include American National Red Cross, Canadian Blood Services, French Red Cross, Japanese Red Cross Society, and European Blood Alliance among others.
Prominent players operating in the blood platelets industry include:
Market, By Platelet Type
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries:
French Red Cross, German Red Cross, Indian Red Cross Society, Italian Red Cross, Japanese Red Cross Society, OneBlood, Red Cross Society of China, South African Red Cross, Spanish Red Cross, and The European Blood Alliance (EBA), are some of the major blood platelets companies worldwide.
Blood platelets industry from the apheresis derived platelets segment reached USD 3 billion in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to allowing for the collection of a larger number of platelets from a single donor compared to whole-blood donations.
Blood platelets market size was USD 5.6 billion in 2023 and is expected to register 4.2% CAGR from 2024-2032 due to the increasing prevalence of chronic and blood-related disorders coupled with growing demand for blood transfusions worldwide.
North America blood platelets industry reached USD 1.5 million in 2023 and is expected to register 2.8% CAGR from 2024-2032 due to significant incidence of blood disorders such as leukemia and lymphoma in the region.